Effect of the knockdown of Cabin1 on p53 in glomerular podocyte

Yueqiang Wen1, Peilan Zhou1, Lingling Liu2

  • 1a Department of Nephrology , The Second Affiliated Hospital, Guangzhou Medical University , Guangzhou , P.R. China and.

Insights

Calcineurin binding protein 1 (Cabin1) increases during podocyte injury and may be a new target for treatment. Cabin1 knockdown reduces p53 expression in podocytes, suggesting a role in kidney disease progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Calcineurin binding protein 1 (Cabin1) inhibits calcineurin (CN) and regulates p53, affecting tumor cell apoptosis.
  • Podocyte injury is a key factor in kidney disease progression.
  • Understanding Cabin1's role in podocyte injury is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the expression of Cabin1 during podocyte injury.
  • To determine the relationship between Cabin1 and p53 in podocytes.
  • To explore Cabin1 as a potential therapeutic target for podocyte injury.

Main Methods:

  • Established a 5/6 nephrectomized rat model and used sham-operated rats as controls.
  • Utilized WT-1 to indicate Cabin1 localization in glomeruli.
  • Injured cultured podocytes with Angiotensin II (AngII) and treated with tacrolimus.
  • Detected protein expression and localization via western blot and immunofluorescence staining.
  • Knocked down Cabin1 using siRNA in cultured podocytes.

Main Results:

  • Cabin1 colocalized with WT-1 in podocyte nuclei in nephrectomized rats.
  • Cabin1 protein levels were significantly increased in nephrectomized rats and AngII-injured podocytes.
  • Cabin1 and p53 colocalized in podocyte nuclei, and Cabin1 knockdown decreased p53 expression.

Conclusions:

  • Cabin1 expression is significantly upregulated during podocyte injury.
  • Cabin1 knockdown leads to decreased p53 expression in cultured podocytes.
  • Cabin1 represents a potential novel target for investigating and treating podocyte injury.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K